Form 4: United Therapeutics EVP Paul Mahon Executes Stock Option and Sells Shares Under 10b5-1 Plan

Paul Mahon, EVP & General Counsel of United Therapeutics, exercised stock options and sold shares of common stock on April 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 4, 2024, Paul A. Mahon, EVP & General Counsel of United Therapeutics Corp, exercised stock options to acquire 6,000 shares of common stock at a price of $117.76 per share.
• Simultaneously, Mahon sold a total of 6,000 shares of common stock in multiple transactions at weighted average prices ranging from $228.842 to $234.0889.
• These transactions were executed under a pre-existing Rule 10b5-1 trading plan adopted on March 17, 2023.
• Following these transactions, Mahon directly owns 36,710 shares of United Therapeutics Corp common stock and 48,000 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions were part of a pre-planned trading strategy. It doesn't necessarily indicate a positive or negative outlook for the company.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating that the sales were planned well in advance and not based on any recent inside information.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. The use of 10b5-1 plans is a standard practice to allow insiders to sell shares without being accused of trading on non-public information.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a form of long-term incentive.
• The exercise and sale of shares by executives are typically monitored by investors to gauge sentiment and potential impact on stock price.
• Companies like Amgen, Gilead, and Biogen also see regular Form 4 filings from their executives related to stock transactions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small number of shares involved.

Key Dates